OrbusNeich Medical Group Holdings Ltd
06929
Company Profile
Business description
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. Its segment include: Asia Pacific region, except Japan and the PRC (APAC), Europe, Middle East & Africa (EMEA), Japan, The PRC, and United States, of which maximum revenue is derived from APAC.
Contact
3rd Floor, Building 20E
Units 303 and 305
Hong Kong Science Park
Shatin New Town
Hong Kong
HKGT: +852 28022288
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,477
Stocks News & Analysis
stocks
ASX retail share remains cheap despite weaker earnings
Weaker profit result drives cut to fair value yet shares remain undervalued.
stocks
AI isn’t an economic moat killer, but it will disrupt industries
How we’re rethinking companies’ competitive advantages in an AI-first world.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,726.50 | 32.00 | -0.37% |
| CAC 40 | 7,846.55 | 102.63 | 1.33% |
| DAX 40 | 22,957.08 | 320.17 | 1.41% |
| Dow JONES (US) | 46,429.49 | 305.43 | 0.66% |
| FTSE 100 | 10,106.84 | 141.68 | 1.42% |
| HKSE | 24,799.91 | 536.04 | -2.12% |
| NASDAQ | 21,929.82 | 167.93 | 0.77% |
| Nikkei 225 | 53,305.30 | 444.32 | -0.83% |
| NZX 50 Index | 12,976.99 | 47.69 | 0.37% |
| S&P 500 | 6,591.90 | 35.53 | 0.54% |
| S&P/ASX 200 | 8,525.70 | 21.30 | -0.25% |
| SSE Composite Index | 3,891.13 | 40.71 | -1.04% |